Vasiliy P. Mishin - Concepedia

Author

Vasiliy P. Mishin

Centers for Disease Control and Prevention

Also Known As

V MISHIN, V. Mishin, V. P. Mishin, V.P. Mishin, Vasiliy P. Mishin, Vasiliy Mishin, Vasiliy P Mishin, Vasiliy P. Mishin, Vasiliy P. Mishin

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Battelle University of Virginia St. Jude Children's Research Hospital

About

Vasiliy P. Mishin is an author at Centers for Disease Control and Prevention specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	32	1.7K
2	Engineering	2	2	109
3	Allergy	2	2	82
4	Health Sciences	1	1	11
5	Biomolecular Engineering	1	1	16

Vasiliy P. Mishin

Publications

Citations

H-Index

Page 1

	Year	Citations
Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection Michael P. Malakhov, Laura Aschenbrenner, Donald F. Smee, Antimicrobial Agents and Chemotherapy	2006	231
Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors Vasiliy P. Mishin, Frederick G. Hayden, Larisa V. Gubareva Antimicrobial Agents and Chemotherapy	2005	217
<i>In Vitro</i>Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses Katrina Sleeman, Vasiliy P. Mishin, Varough Deyde, Antimicrobial Agents and Chemotherapy VaccinationMedicineImmunologyDrug-resistant InfluenzaAntiviral Drug Development	2010	141
Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014–2015 Brendan Flannery, Richard K. Zimmerman, Larisa V. Gubareva, The Journal of Infectious Diseases	2016	121
Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons Larisa V. Gubareva, Vasiliy P. Mishin, Mira C. Patel, Eurosurveillance Virus EpidemiologyViral Polymerase StructureViral DiagnosticsMedicineBaloxavir Susceptibility	2019	113
Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein Gallen Triana‐Baltzer, Larisa V. Gubareva, John M. Nicholls, PLoS ONE	2009	107
Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N Donald F. Smee, Katherine Bailey, Ming Hung Wong, Antiviral Research VaccinationMedicineViral PathogenesisAntiviral Drug DevelopmentVirology	2008	103
Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility <i>in vitro</i> Larisa V. Gubareva, A. Angelica Trujillo, Margaret Okomo‐Adhiambo, Antiviral Therapy	2010	94
A New Strategy in Design of (+)RNA Virus Infectious Clones Enabling Their Stable Propagation in E. coli Vladimir Yamshchikov, Vasiliy P. Mishin, Fabio Cominelli Virology Viral ReplicationE. ColiEngineeringSynthetic VirologySynthetic Biology	2001	93
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011–2018 Patricia A. Jorquera, Vasiliy P. Mishin, Anton Chesnokov, Scientific Reports	2019	85

Page 1